Diabeloop Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 117

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $16.2M

  • Investors
  • 23

Diabeloop General Information

Description

Developer of an AI-based blood sugar monitoring device designed to improve diabetes treatment. The company's device automatically delivers the appropriate dose of insulin to patients and has a sensor that measures patients' glucose levels, a pump that delivers insulin, and a smartphone application with an embedded algorithm and patient interface that links the sensor and the pump, enabling patients to have lightened mental load and live their life without interruptions.

Contact Information

Website
www.diabeloop.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 17 Rue Félix Esclangon
  • Cedex 1
  • 38000 Grenoble
  • France
+33 04
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Therapeutic Devices
Other Devices and Supplies
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 17 Rue Félix Esclangon
  • Cedex 1
  • 38000 Grenoble
  • France
+33 04

Diabeloop Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Diabeloop Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series C) 04-Mar-2024 $16.2M Completed Generating Revenue
7. Later Stage VC (Series C) 02-Jun-2022 Completed Generating Revenue
6. Grant 31-Mar-2021 Completed Generating Revenue
5. Early Stage VC (Series B) 10-Sep-2019 Completed Generating Revenue
4. Early Stage VC (Series A) 21-Sep-2017 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
1. Grant 01-Jan-2015 Completed Startup
To view Diabeloop’s complete valuation and funding history, request access »

Diabeloop Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
P2 shares
P2 shares
P Shares 243,512 $1.107962 $34.13 $34.13 1x $34.13 24.24%
To view Diabeloop’s complete cap table history, request access »

Diabeloop Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an AI-based blood sugar monitoring device designed to improve diabetes treatment. The company's device auto
Monitoring Equipment
Grenoble, France
117 As of 2024

San Diego, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Diabeloop Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GlySens Venture Capital-Backed San Diego, CA
DexCom Formerly VC-backed San Diego, CA
GlucoWise Formerly Accelerator/Incubator backed London, United Kingdom
POGO Automatic Private Equity-Backed Fremont, CA
DreaMed Venture Capital-Backed Petah Tikva, Israel
You’re viewing 5 of 22 competitors. Get the full list »

Diabeloop Patents

  • 45

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 35

    Pending

  • Expiring in next 12 mo

Diabeloop Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240221889-A1 System for ensuring the safety of a quantity of insulin to be injected and medical system for regulating a glycemia of a person Pending 28-Dec-2022
EP-4394787-A1 System for ensuring the safety of a quantity of insulin to be injected and medical system for regulating a glycemia of a person Pending 28-Dec-2022
EP-4376015-A1 Device and method for determining a recommendation value of a control parameter of a fluid infusion device Pending 23-Nov-2022
US-20240165329-A1 Device and method for determining a recommendation value of a control parameter of a fluid infusion device Pending 23-Nov-2022
US-20240165330-A1 Method for determining an uncertainty level of deep reinforcement learning network and device implementing such method Active 23-Nov-2022 A61M5/1723
To view Diabeloop’s complete patent history, request access »

Diabeloop Executive Team (7)

Name Title Board Seat
François Miceli Chief Executive Officer, President & Chairman
Pierre-Yves Benhamou MD Chief Medical Officer, Medical Director & President
Guillaume Charpentier Co-Founder, Chief Medical Officer & Board of Directors
Erik Huneker Co-Founder & Chief Science and Technology Officer
Cécile Ferracci Chief Commercial Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Diabeloop Board Members (4)

Name Representing Role Since
Catherine Dunand Self Non-executive President of the board & Board Member
Celia Hart Ph.D Supernova Invest Board Member
Guillaume Charpentier Diabeloop Co-Founder, Chief Medical Officer & Board of Directors
You’re viewing 3 of 4 board members. Get the full list »

Diabeloop Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Diabeloop Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adagia Partners PE/Buyout Minority
Crédit Agricole Alpes Développement Corporate Venture Capital Minority
Crédit Agricole Sud Rhône-Alpes Lender/Debt Provider Minority
Innovacom (Paris) Venture Capital Minority
LBO France PE/Buyout Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Diabeloop FAQs

  • When was Diabeloop founded?

    Diabeloop was founded in 2015.

  • Who is the founder of Diabeloop?

    Guillaume Charpentier and Erik Huneker are the founders of Diabeloop.

  • Who is the CEO of Diabeloop?

    François Miceli is the CEO of Diabeloop.

  • Where is Diabeloop headquartered?

    Diabeloop is headquartered in Grenoble, France.

  • What is the size of Diabeloop?

    Diabeloop has 117 total employees.

  • What industry is Diabeloop in?

    Diabeloop’s primary industry is Monitoring Equipment.

  • Is Diabeloop a private or public company?

    Diabeloop is a Private company.

  • What is Diabeloop’s current revenue?

    The current revenue for Diabeloop is .

  • How much funding has Diabeloop raised over time?

    Diabeloop has raised $141M.

  • Who are Diabeloop’s investors?

    Adagia Partners, Crédit Agricole Alpes Développement, Crédit Agricole Sud Rhône-Alpes, Innovacom (Paris), and LBO France are 5 of 23 investors who have invested in Diabeloop.

  • Who are Diabeloop’s competitors?

    GlySens, DexCom, GlucoWise, POGO Automatic, and DreaMed are some of the 22 competitors of Diabeloop.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »